Pharmafile Logo

VJOncology

- PMLiVE

With US approval, GSK now needs rapid uptake for COPD triple

Aims to quickly launch the predicted blockbuster to revive its R&D portfolio

Bristol-Myers Squibb (BMS) building

NICE says OK to Opdivo for lung cancer via CDF

Comes after BMS drops the price of its PD-1 inhibitor

- PMLiVE

MSD’s Keytruda wins new bladder cancer indication in Europe

Will treat locally advanced or mUC patients

Ljubisav Matejevic joins health IT firm Ascom

He is appointed to central and eastern Europe role

Why we do it

Focussing on innovation

- PMLiVE

LEO: Patients benefit from transparency

Paving the way for openness in pharma

- PMLiVE

The Truth about Doctors

‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and...

- PMLiVE

Thinking clearly and imagining better

Earning trust by temporarily ignoring business plans and goals

- PMLiVE

AbbVie and Roche plan Venclexta combo filings in leukaemia

MURANO trial shows the duo’s treatment extends PFS

- PMLiVE

Teva offloads women’s health unit in quickfire deals

The Israeli pharma group is also set to sell its oncology and pain business

Almirall looks to crowdsource new skin health treatments

Launches open innovation platform AlmirallShare

Four Health triumphs at PM Society Digital Awards

This year’s PM Society Digital Awards brought smiles all round Four Health and its clients, Johnson & Johnson and Novo Nordisk, with the agencies media and communications teams walking away...

Four Agency Worldwide

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links